Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cannabis for Spasticity in Multiple Sclerosis

This study has been terminated.
(Unable to complete subject recruitment)
Sponsor:
Collaborator:
National Multiple Sclerosis Society
Information provided by (Responsible Party):
University of California, Davis
ClinicalTrials.gov Identifier:
NCT00682929
First received: May 19, 2008
Last updated: November 14, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2017
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)